Information Provided By: 
Fly News Breaks for December 9, 2016
INGN
Dec 9, 2016 | 07:55 EDT
Leerink analyst Danielle Antalffy raised her price target for Inogen to $80 from $60, citing still highly underpenetrated market opportunity as Portable Oxygen Concentrators continue to drive shift to standard of care. The analyst also views the company's CEO transition as a positive indication that Inogen's business is stable, with a well-thought-out long-term growth plan already in place. She reiterates an Outperform rating on the shares.
News For INGN From the Last 2 Days
There are no results for your query INGN
